🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Combination therapy in pulmonary arterial hypertension (PAH) has been the s...
Status
Completed
Location
Providence Medical Foundation
Start Date
2019-07-29
Trial ID
NCT03904693
This is a study to evaluate whether macitentan is an effective and safe tre...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-07-11
Trial ID
NCT03153111
Treatments Being Tested
The purpose of the study is to evaluate the effect of macitentan 75 mg vers...
Status
Terminated
Location
University of California San Diego Medical Center
Start Date
2020-07-07
Trial ID
NCT04271475
Treatments Being Tested
Potential therapy with MACITENTAN in the treatment of Chronic Lung Allograf...
Status
Withdrawn
Location
University of Califonia, Los Angeles
Start Date
2016-09
Trial ID
NCT02893176
Treatments Being Tested
The purpose of this study is to demonstrate superiority of macitentan 75 mi...
Status
Active Not Recruiting
Location
Mayo Clinic
Start Date
2020-06-30
Trial ID
NCT04273945
Treatments Being Tested
About half of patients who suffer of a pulmonary embolism (blood clots in t...
Status
Withdrawn
Location
University of Maryland Medical Center
Start Date
2024-05-01
Trial ID
NCT05946811
Treatments Being Tested
The DUAL-1 study is designed as a multicenter, double-blind two-period stud...
Status
Completed
Location
University of Arizona Arthritis Center
Start Date
2011-12
Trial ID
NCT01474109
Treatments Being Tested
The main purpose of this study is to evaluate the safety and efficacy of ta...
Status
Completed
Location
Children's Heathcare of Atlanta, Inc. at Egleston
Start Date
2014-02-05
Trial ID
NCT01824290
Treatments Being Tested
The DUAL-2 study is designed as a multicenter, double-blind two-period stud...
Status
Terminated
Location
Multiple Locations
Start Date
2011-12
Trial ID
NCT01474122
Treatments Being Tested